| Questions |
|
Neph. Pre-Meeting |
|
Neph. Post-Meeting |
|
Surg. Pre-Meeting |
|
Surg. Post-Meeting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| #1
Which patients do you consider poor AVF Candidates? |
|
|
|
| Nobody |
|
|
|
2 |
|
|
|
|
|
|
| Geriatric/Elderly |
|
7 |
|
|
|
1 |
|
0 |
|
|
| Cardiovas.
Disease |
|
2 |
|
2 |
|
1 |
|
1 |
|
|
| Prior Failed
Access |
|
5 |
|
0 |
|
1 |
|
1 |
|
|
| Drug Abusers |
|
9 |
|
2 |
|
8 |
|
2 |
|
|
| Diabetic |
|
9 |
|
2 |
|
1 |
|
0 |
|
|
| Obese |
|
5 |
|
1 |
|
5 |
|
2 |
|
|
| Long term
Steroid Use |
|
4 |
|
0 |
|
3 |
|
1 |
|
|
| Other
Diseases |
|
10 |
|
5 |
|
5 |
|
4 |
|
|
| Pat. Pref.
for Aes. Rsn. |
|
0 |
|
1 |
|
0 |
|
0 |
|
|
| Short Life
Expectancy |
|
6 |
|
4 |
|
5 |
|
4 |
|
|
| Transplant
list |
|
3 |
|
3 |
|
1 |
|
2 |
|
|
|
|
|
|
|
| #3
Has the mtg. changed your way of thinking re: suitability of AVF? (post only,
not pre) |
|
|
|
|
|
| Yes |
|
|
|
13 |
|
|
|
4 |
|
|
| No |
|
|
|
6 |
|
|
|
2 |
|
|
| Comments |
|
|
|
3-grafts should be converted |
|
|
|
1-change the way I do mapping |
|
|
|
|
to fistulas per vasc. Guidelines |
|
|
|
1-more
pre-op lead time |
|
|
|
|
4-be more aggressive to AVF |
|
|
|
1-will try more upper arm Fistulas |
|
|
|
|
1-try multiple AVF before AVG |
|
|
|
1-conversion of AVG to AVF |
|
|
|
|
3-good data to help convince |
|
|
|
|
|
|
|
|
my team |
|
|
|
|
|
|
|
|
|
|
|
|
| #4
Most Significant area of Discussion? (post only, not pre) |
|
|
|
|
|
| Comments |
|
|
|
2-zero graft rate |
|
|
|
3-vein transposition of AVF |
|
|
|
|
2-pre-esrd eval of access |
|
|
|
1-philosophy for using AVF |
|
|
|
|
alternatives |
|
|
|
1-concept of access manager |
|
|
|
|
4-access planning |
|
|
|
1-surgical aspects |
|
|
|
|
6-Nguyen & Griffith |
|
|
|
3-technique of "how to" |
|
|
|
|
3-different techniques of AVF |
|
|
|
1-imaging studies to improve sel. |
|
|
|
|
creation |
|
|
|
|
|
|
|
|
3-more talking between Neph |
|
|
|
|
|
|
|
and Surgeon |
|
|
|
|
|
|
|
|
|
|
|
|
| Questions (Cont'd) |
|
Neph. Pre-Meeting |
|
Neph. Post-Meeting |
|
Surg. Pre-Meeting |
|
Surg. Post-Meeting |
|
|
|
|
|
|
|
|
| #5
Will you make any practice changes due to info today? (post only, not pre) |
|
|
|
|
|
|
|
|
|
|
|
|
| Yes |
|
|
|
15 |
|
|
|
7 |
|
|
| No |
|
|
|
0 |
|
|
|
0 |
|
|
| Maybe |
|
|
|
1 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
| Comments |
|
|
|
3-convert AVG to AVF |
|
|
|
1-coninue on-going efforts to est. |
|
|
|
|
4-educate surgeons |
|
|
|
database of access patients |
|
|
|
|
6-more involved in pre-op |
|
|
|
1-more vascular lab studies |
|
|
|
|
evaluations |
|
2-importance of vein mapping |
|
|
1-we have lots of work to do to |
|
1-will try more fistulas |
|
|
get out of our comfortable but |
|
|
|
|
dysfunctional rut if we are to |
|
|
|
|
improve. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|